These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16724943)

  • 21. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
    Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
    Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo.
    Wang T; Li QH; Hao GP; Zhai J
    Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model.
    Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A
    J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.
    Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T
    Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction.
    Morishita R; Sugimoto T; Aoki M; Kida I; Tomita N; Moriguchi A; Maeda K; Sawa Y; Kaneda Y; Higaki J; Ogihara T
    Nat Med; 1997 Aug; 3(8):894-9. PubMed ID: 9256281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow up of initial clinical cases with NF-kappaB decoy oligodeoxynucleotide transfection at the site of coronary stenting.
    Egashira K; Suzuki J; Ito H; Aoki M; Isobe M; Morishita R
    J Gene Med; 2008 Jul; 10(7):805-9. PubMed ID: 18425985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy.
    Osako MK; Nakagami H; Morishita R
    Curr Top Med Chem; 2012; 12(15):1603-7. PubMed ID: 22762556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression of intracranial aneurysms by simultaneous inhibition of nuclear factor-κB and Ets with chimeric decoy oligodeoxynucleotide treatment.
    Aoki T; Kataoka H; Nishimura M; Ishibashi R; Morishita R; Miyamoto S
    Neurosurgery; 2012 Jun; 70(6):1534-43; discussion 1543. PubMed ID: 22186838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The inhibitory effects of dumb-bell decoy oligodeoxynucleotides targeting NF-kappaB on the growth of multiple myeloma cells and IL-6 expression].
    Jiang HL; Xue WJ; Liu H; Chen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):47-50. PubMed ID: 16388744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo.
    Kang JH; Chae YM; Park KK; Kim CH; Lee IS; Chang YC
    J Cell Biochem; 2008 Feb; 103(2):663-74. PubMed ID: 17557290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of decoy oligodeoxynucleotides-based approach to renal diseases.
    Tomita N; Azuma H; Kaneda Y; Ogihara T; Morishita R
    Curr Drug Targets; 2004 Nov; 5(8):717-33. PubMed ID: 15578952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa.
    Gambari R; Borgatti M; Bezzerri V; Nicolis E; Lampronti I; Dechecchi MC; Mancini I; Tamanini A; Cabrini G
    Biochem Pharmacol; 2010 Dec; 80(12):1887-94. PubMed ID: 20615393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor κB and ets prevents abdominal aortic aneurysm in rat model.
    Miyake T; Aoki M; Osako MK; Shimamura M; Nakagami H; Morishita R
    Mol Ther; 2011 Jan; 19(1):181-7. PubMed ID: 20877343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis.
    Matsuda N; Hattori Y; Jesmin S; Gando S
    Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of a decoy against the activator protein-1 binding site suppresses neointimal thickening in rabbit balloon-injured arteries.
    Kume M; Komori K; Matsumoto T; Onohara T; Takeuchi K; Yonemitsu Y; Sugimachi K
    Circulation; 2002 Mar; 105(10):1226-32. PubMed ID: 11889018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.
    Tomita T; Takeuchi E; Tomita N; Morishita R; Kaneko M; Yamamoto K; Nakase T; Seki H; Kato K; Kaneda Y; Ochi T
    Arthritis Rheum; 1999 Dec; 42(12):2532-42. PubMed ID: 10615998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model.
    Miyake T; Aoki M; Nakashima H; Kawasaki T; Oishi M; Kataoka K; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2006 Apr; 13(8):695-704. PubMed ID: 16397509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amelioration of collagen-induced arthritis using antigen-loaded dendritic cells modified with NF-κB decoy oligodeoxynucleotides.
    Jiang H; Hu H; Zhang Y; Yue P; Ning L; Zhou Y; Shi P; Yuan R
    Drug Des Devel Ther; 2017; 11():2997-3007. PubMed ID: 29075103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model.
    Hashiya N; Aoki M; Tachibana K; Taniyama Y; Yamasaki K; Hiraoka K; Makino H; Yasufumi K; Ogihara T; Morishita R
    Biochem Biophys Res Commun; 2004 Apr; 317(2):508-14. PubMed ID: 15063786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of novel decoy oligonucleotides: advantages of circular dumb-bell decoy.
    Tomita N; Tomita T; Yuyama K; Tougan T; Tajima T; Ogihara T; Morishita R
    Curr Opin Mol Ther; 2003 Apr; 5(2):107-12. PubMed ID: 12772498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.